Moderna (MRNA): are the analysts right?

Moderna · Health Care · ref. ETF XLV · 50 calls · price $79.77
What the company does: Moderna développe et commercialise des vaccins à ARN messager pour maladies respiratoires et autres affections.
📈 1-year price
$79.77+145.1% over range
Jul 8, 25low $22.36 · high $81.8Jul 7, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Hold
14% recommend buying · 7 analysts
⚠️ The stock trades above the median target: it has beaten expectations. The “Hold” reflects conviction on the company, but the remaining quantified upside is low/negative.

🎯 Analyst price target on MRNA

High target · 1 analyst$77-3.5%
Median target · 5 analysts$49-38.6%
Low target · 1 analyst$45-43.6%
Current price$79.77

🗳️ The analyst consensus

Analyst breakdown · 7 (6 months)
Strong Buy0%
Buy14%
Hold71%
Sell14%
Strong Sell0%

✅ Historical analyst reliability on MRNA

Most reliable analysts on MRNA (% profitable · 365j · ≥2 calls)
UBS 67% +33.0% 3
JP Morgan 33% -29.7% 3

📊 What $1,000 invested in Moderna would be worth

In short — $1,000 invested in Moderna 10 years ago would be worth $3,765 today, i.e. +18%/yr on average. Best year: 2020 (+453%), worst: 2024 (-58%). Price performance, excluding dividends.

If I'd invested $1,000 in Moderna

InvestmentWorth todayGain
1 years ago$1,660+66%
3 years ago$390-61%
5 years ago$670-33%
since inception (2018)$3,765+277%

Return by year (Moderna)

YearReturn$1,000 invested at year start
2026 (YTD)+127%$2,269 (+127%)
2025-27%$1,660 (+66%)
2024-58%$704 (-30%)
2023-45%$390 (-61%)
2022-29%$276 (-72%)
2021+143%$670 (-33%)
2020+453%$3,707 (+271%)
2019+11%$4,129 (+313%)
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.

🔎 Detailed analyses

👥 Analysts & forecasts📊 Returns & performance
📈 Fundamentals, technical momentum and live news will show here on the final site (loaded live from the same origin as the API).

📋 All analyst calls on MRNA

RBC Capital
Jul 7, 26
■ Sector Perform neutral · not a buy · 🎯$45
Today : $79.77 — gap to target -44%
🎯 on MRNA : no call matured yet · 📊 on Health : 43% · -1.9% (381 calls)
in progress (365j)
matures : Jul 7, 27
▼ Underperform · 🎯$38
Today : $79.77 — upside -52%
🎯 on MRNA : 0% (1 call matured) · 📊 on Health : 48.6% · +2.3% (352 calls)
in progress (365j)
matures : Jul 7, 27
Piper Sandler
Jun 26, 26
▲ Overweight · 🎯$77
Price at call : $69.7 — upside +10%
Today : $79.77 — upside -3%
🎯 on MRNA : 0% (1 call matured) · 📊 on Health : 47% · -1.0% (313 calls)
in progress (365j)
matures : Jun 26, 27
▼ Underperform · 🎯$34
Price at call : $47.73 — upside -29%
Today : $79.77 — upside -57%
🎯 on MRNA : 0% (1 call matured) · 📊 on Health : 48.6% · +2.3% (352 calls)
in progress (365j)
matures : Jun 8, 27
UBS
May 4, 26
■ Neutral neutral · not a buy · 🎯$45
Price at call : $46.71 — gap to target -4%
Today : $79.77 — gap to target -44%
🎯 on MRNA : 67% (3 calls matureds) · 📊 on Health : 52.1% · +3.4% (340 calls)
in progress (365j)
matures : May 4, 27
■ Neutral neutral · not a buy · 🎯$49
Price at call : $46.71 — gap to target +5%
Today : $79.77 — gap to target -39%
🎯 on MRNA : no call matured yet · 📊 on Health : 50.8% · +2.0% (240 calls)
in progress (365j)
matures : May 4, 27
■ In-Line neutral · not a buy · 🎯$50
Price at call : $46.71 — gap to target +7%
Today : $79.77 — gap to target -37%
🎯 on MRNA : no call matured yet · 📊 on Health : 47.6% · +1.3% (147 calls)
in progress (365j)
matures : May 4, 27
RBC Capital
May 4, 26
■ Sector Perform neutral · not a buy · 🎯$38
Price at call : $46.71 — gap to target -19%
Today : $79.77 — gap to target -52%
🎯 on MRNA : no call matured yet · 📊 on Health : 43% · -1.9% (381 calls)
in progress (365j)
matures : May 4, 27
Barclays
Apr 2, 26
■ Equal-Weight neutral · not a buy · 🎯$48
Price at call : $48.77 — gap to target -2%
Today : $79.77 — gap to target -40%
🎯 on MRNA : 0% (1 call matured) · 📊 on Health : 50.1% · +2.2% (617 calls)
in progress (365j)
matures : Apr 2, 27
Piper Sandler
Feb 23, 26
▲ Overweight · 🎯$69
Price at call : $50.29 — upside +37%
Today : $79.77 — upside -14%
🎯 on MRNA : 0% (1 call matured) · 📊 on Health : 47% · -1.0% (313 calls)
in progress (365j)
matures : Feb 23, 27
Goldman Sachs
Feb 17, 26
■ Neutral neutral · not a buy · 🎯$41
Price at call : $46.6 — gap to target -12%
Today : $79.77 — gap to target -49%
🎯 on MRNA : no call matured yet · 📊 on Health : 50.8% · +2.0% (240 calls)
in progress (365j)
matures : Feb 17, 27
RBC Capital
Feb 17, 26
■ Sector Perform neutral · not a buy · 🎯$30
Price at call : $46.6 — gap to target -36%
Today : $79.77 — gap to target -62%
🎯 on MRNA : no call matured yet · 📊 on Health : 43% · -1.9% (381 calls)
in progress (365j)
matures : Feb 17, 27
■ In-Line neutral · not a buy · 🎯$35
Price at call : $46.6 — gap to target -25%
Today : $79.77 — gap to target -56%
🎯 on MRNA : no call matured yet · 📊 on Health : 47.6% · +1.3% (147 calls)
in progress (365j)
matures : Feb 17, 27
■ Equal-Weight neutral · not a buy · 🎯$28
Price at call : $29.92 — gap to target -6%
Today : $79.77 — gap to target -65%
🎯 on MRNA : no call matured yet · 📊 on Health : 51.7% · +5.3% (804 calls)
in progress (365j)
matures : Dec 12, 26
Jefferies
Dec 12, 25
■ Hold neutral · not a buy · 🎯$30
Price at call : $29.46 — gap to target +2%
Today : $79.77 — gap to target -62%
🎯 on MRNA : no call matured yet · 📊 on Health : 50.5% · +4.5% (376 calls)
in progress (365j)
matures : Dec 12, 26
Piper Sandler
Nov 21, 25
▲ Overweight · 🎯$63
Price at call : $24.15 — upside +161%
Today : $79.77 — upside -21%
🎯 on MRNA : 0% (1 call matured) · 📊 on Health : 47% · -1.0% (313 calls)
in progress (365j)
matures : Nov 21, 26
RBC Capital
Nov 21, 25
■ Sector Perform neutral · not a buy · 🎯$25
Price at call : $24.15 — gap to target +4%
Today : $79.77 — gap to target -69%
🎯 on MRNA : no call matured yet · 📊 on Health : 43% · -1.9% (381 calls)
in progress (365j)
matures : Nov 21, 26
▼ Underperform · 🎯$18
Price at call : $24.15 — upside -25%
Today : $79.77 — upside -77%
🎯 on MRNA : no call matured yet · 📊 on Health : 57.1% · +6.2% (35 calls)
in progress (365j)
matures : Nov 21, 26
▼ Underperform · 🎯$21
Price at call : $24.76 — upside -15%
Today : $79.77 — upside -74%
🎯 on MRNA : 0% (1 call matured) · 📊 on Health : 48.6% · +2.3% (352 calls)
in progress (365j)
matures : Nov 10, 26
Barclays
Nov 7, 25
■ Equal-Weight neutral · not a buy · 🎯$25
Price at call : $24.76 — gap to target +1%
Today : $79.77 — gap to target -69%
🎯 on MRNA : 0% (1 call matured) · 📊 on Health : 50.1% · +2.2% (617 calls)
in progress (365j)
matures : Nov 7, 26
UBS
Oct 23, 25
▲ Buy · 🎯$40
Price at call : $26.74 — upside +50%
Today : $79.77 — upside -50%
🎯 on MRNA : 67% (3 calls matureds) · 📊 on Health : 52.1% · +3.4% (340 calls)
in progress (365j)
matures : Oct 23, 26
JP Morgan
Oct 23, 25
▼ Underweight · 🎯$25
Price at call : $26.74 — upside -7%
Today : $79.77 — upside -69%
🎯 on MRNA : 33% (3 calls matureds) · 📊 on Health : 53.6% · +5.2% (349 calls)
in progress (365j)
matures : Oct 23, 26
Citigroup
Oct 23, 25
■ Neutral neutral · not a buy · 🎯$28
Price at call : $26.25 — gap to target +7%
Today : $79.77 — gap to target -65%
🎯 on MRNA : no call matured yet · 📊 on Health : 53.4% · +2.8% (496 calls)
in progress (365j)
matures : Oct 23, 26
Needham
Oct 20, 25
■ Hold neutral · not a buy
🎯 on MRNA : no call matured yet · 📊 on Health : 51% · +4.4% (153 calls)
in progress (365j)
matures : Oct 20, 26
■ Equal-Weight neutral · not a buy · 🎯$32
Price at call : $26.74 — gap to target +20%
Today : $79.77 — gap to target -60%
🎯 on MRNA : no call matured yet · 📊 on Health : 51.7% · +5.3% (804 calls)
in progress (365j)
matures : Oct 10, 26
▼ Underperform · 🎯$15
Price at call : $25.35 — upside -41%
Today : $79.77 — upside -81%
🎯 on MRNA : no call matured yet · 📊 on Health : 57.1% · +6.2% (35 calls)
in progress (365j)
matures : Aug 22, 26
Barclays
Aug 4, 25
■ Equal-Weight neutral · not a buy · 🎯$31
Price at call : $27.47 — gap to target +13%
Today : $79.77 — gap to target -61%
🎯 on MRNA : 0% (1 call matured) · 📊 on Health : 50.1% · +2.2% (617 calls)
in progress (365j)
matures : Aug 4, 26
▼ Underperform · 🎯$25
Price at call : $34.67 — upside -28%
Today : $79.77 — upside -69%
🎯 on MRNA : 0% (1 call matured) · 📊 on Health : 48.6% · +2.3% (352 calls)
in progress (365j)
matures : Jul 22, 26
JP Morgan
May 22, 25
▼ Underweight · 🎯$26
Price at call : $26.26 — upside -1%
Today : $79.77 — upside -67%
Expected -1% · Actual +79% · Reason (≤ −15%) : ✗ No
🎯 on MRNA : 33% (3 calls matureds) · 📊 on Health : 53.6% · +5.2% (349 calls)
-79.1%
stock +79% · XLV +14%
UBS
May 3, 25
▲ Buy · 🎯$70
Price at call : $27.84 — upside +151%
Today : $79.77 — upside -12%
Expected +151% · Actual +70% · Reason (≥ +15%) : ✓ Yes
🎯 on MRNA : 67% (3 calls matureds) · 📊 on Health : 52.1% · +3.4% (340 calls)
+69.9%
stock +70% · XLV +5%
Barclays
May 2, 25
■ Equal-Weight neutral · not a buy · 🎯$40
Price at call : $27.84 — gap to target +44%
Today : $79.77 — gap to target -50%
🎯 on MRNA : 0% (1 call matured) · 📊 on Health : 50.1% · +2.2% (617 calls)
in progress (365j)
matures : May 2, 26
RBC Capital
May 2, 25
■ Sector Perform neutral · not a buy · 🎯$28
Price at call : $27.84 — gap to target +1%
Today : $79.77 — gap to target -65%
🎯 on MRNA : no call matured yet · 📊 on Health : 43% · -1.9% (381 calls)
in progress (365j)
matures : May 2, 26
■ In-Line neutral · not a buy · 🎯$32
Price at call : $27.61 — gap to target +16%
Today : $79.77 — gap to target -60%
🎯 on MRNA : no call matured yet · 📊 on Health : 47.6% · +1.3% (147 calls)
in progress (365j)
matures : May 2, 26
■ Equal-Weight neutral · not a buy · 🎯$32
Price at call : $24.5 — gap to target +31%
Today : $79.77 — gap to target -60%
🎯 on MRNA : no call matured yet · 📊 on Health : 51.7% · +5.3% (804 calls)
in progress (365j)
matures : Apr 9, 26
JP Morgan
Mar 21, 25
▼ Underweight · 🎯$33
Price at call : $34.17 — upside -3%
Today : $79.77 — upside -59%
Expected -3% · Actual +50% · Reason (≤ −15%) : ✗ No
🎯 on MRNA : 33% (3 calls matureds) · 📊 on Health : 53.6% · +5.2% (349 calls)
-50.1%
stock +50% · XLV -2%
Citigroup
Mar 13, 25
■ Neutral neutral · not a buy · 🎯$40
Price at call : $34.62 — gap to target +16%
Today : $79.77 — gap to target -50%
🎯 on MRNA : no call matured yet · 📊 on Health : 53.4% · +2.8% (496 calls)
in progress (365j)
matures : Mar 13, 26
UBS
Feb 19, 25
▲ Buy · 🎯$78
Price at call : $33.73 — upside +131%
Today : $79.77 — upside -2%
Expected +131% · Actual +48% · Reason (≥ +15%) : ✓ Yes
🎯 on MRNA : 67% (3 calls matureds) · 📊 on Health : 52.1% · +3.4% (340 calls)
+47.9%
stock +48% · XLV +7%
RBC Capital
Feb 18, 25
■ Sector Perform neutral · not a buy · 🎯$40
Price at call : $35.9 — gap to target +11%
Today : $79.77 — gap to target -50%
🎯 on MRNA : no call matured yet · 📊 on Health : 43% · -1.9% (381 calls)
in progress (365j)
matures : Feb 18, 26
Barclays
Feb 18, 25
■ Equal-Weight neutral · not a buy · 🎯$45
Price at call : $35.75 — gap to target +26%
Today : $79.77 — gap to target -44%
🎯 on MRNA : 0% (1 call matured) · 📊 on Health : 50.1% · +2.2% (617 calls)
in progress (365j)
matures : Feb 18, 26
▼ Underperform · 🎯$34
Price at call : $30.93 — upside +10%
Today : $79.77 — upside -57%
Expected +10% · Actual +31% · Reason (≤ −15%) : ✗ No
🎯 on MRNA : 0% (1 call matured) · 📊 on Health : 48.6% · +2.3% (352 calls)
-31.0%
stock +31% · XLV +7%
■ In-Line neutral · not a buy · 🎯$50
Price at call : $44.94 — gap to target +11%
Today : $79.77 — gap to target -37%
🎯 on MRNA : no call matured yet · 📊 on Health : 47.6% · +1.3% (147 calls)
in progress (365j)
matures : Jan 27, 26
■ Equal-Weight neutral · not a buy · 🎯$38
Price at call : $33.76 — gap to target +13%
Today : $79.77 — gap to target -52%
🎯 on MRNA : no call matured yet · 📊 on Health : 51.7% · +5.3% (804 calls)
in progress (365j)
matures : Jan 15, 26
UBS
Jan 8, 25
▲ Buy · 🎯$96
Price at call : $42.25 — upside +127%
Today : $79.77 — upside +20%
Expected +127% · Actual -19% · Reason (≥ +15%) : ✗ No
🎯 on MRNA : 67% (3 calls matureds) · 📊 on Health : 52.1% · +3.4% (340 calls)
-18.8%
stock -19% · XLV +13%
■ Hold neutral · not a buy
🎯 on MRNA : no call matured yet · 📊 on Health : 56.4% · +2.9% (156 calls)
in progress (365j)
matures : Dec 18, 25
JP Morgan
Nov 26, 24
▼ Underweight · 🎯$45
Price at call : $43.39 — upside +4%
Today : $79.77 — upside -44%
Expected +4% · Actual -40% · Reason (≤ −15%) : ✓ Yes
🎯 on MRNA : 33% (3 calls matureds) · 📊 on Health : 53.6% · +5.2% (349 calls)
+40.1%
stock -40% · XLV +7%
Piper Sandler
Nov 18, 24
▲ Overweight · 🎯$69
Price at call : $37.29 — upside +85%
Today : $79.77 — upside -14%
Expected +85% · Actual -35% · Reason (≥ +15%) : ✗ No
🎯 on MRNA : 0% (1 call matured) · 📊 on Health : 47% · -1.0% (313 calls)
-35.2%
stock -35% · XLV +8%
HSBC
Nov 18, 24
▲ Buy · 🎯$58
Price at call : $39.51 — upside +47%
Today : $79.77 — upside -27%
Expected +47% · Actual -37% · Reason (≥ +15%) : ✗ No
🎯 on MRNA : 0% (1 call matured) · 📊 on Health : 53.6% · +1.4% (28 calls)
-36.9%
stock -37% · XLV +8%
▼ Underperform · 🎯$40
Price at call : $36.85 — upside +9%
Today : $79.77 — upside -50%
Expected +9% · Actual -33% · Reason (≤ −15%) : ✓ Yes
🎯 on MRNA : 100% (1 call matured) · 📊 on Health : 60.9% · +4.3% (46 calls)
+32.8%
stock -33% · XLV +7%
Barclays
Nov 8, 24
▲ Overweight · 🎯$111
Price at call : $42.75 — upside +160%
Today : $79.77 — upside +39%
Expected +160% · Actual -42% · Reason (≥ +15%) : ✗ No
🎯 on MRNA : 0% (1 call matured) · 📊 on Health : 50.1% · +2.2% (617 calls)
-42.1%
stock -42% · XLV -1%
Needham
Nov 8, 24
■ Hold neutral · not a buy
🎯 on MRNA : no call matured yet · 📊 on Health : 51% · +4.4% (153 calls)
in progress (365j)
matures : Nov 8, 25
JPI AI Analyst AI assistant · JPI Invest
Answers based on the tool’s data · not financial advice · full version (free)